eCARTv5 Clinical Deterioration Suite (“eCART”) vs Google Med-PaLM 2

AgileMD's eCARTv5 is designed for seamless integration into existing EHR workflows, providing real-time alerts and embedded clinical pathways. This direct integration and focus on minimizing false alarms suggest a highly intuitive user interface and a design aimed at decreasing clinician workload. Google Med-PaLM 2, while powerful, is an API-based large language model, implying a need for custom integration and development to be fully usable within a clinical setting, which could be more complex for end-users.

eCARTv5 is an FDA-cleared Software as a Medical Device (SaMD) specifically designed for continuous patient risk assessment and prediction of clinical deterioration (death or ICU transfer) in hospitalized adult patients. It has undergone extensive retrospective and prospective validation in large, diverse patient cohorts, demonstrating superior accuracy compared to other early warning scores. Med-PaLM 2, while achieving expert-level performance on medical licensing exams and showing promise in clinical reasoning and multimodal data analysis, is still primarily a large language model and is currently available for limited testing and exploration of use cases, with outputs requiring validation by qualified healthcare professionals.

Both tools require contacting the vendor for a tailored quote, making direct pricing comparison difficult. AgileMD's eCARTv5 emphasizes cost efficiency through reduced unnecessary tests and procedures, while Med-PaLM 2's value proposition lies in accelerating diagnostics, enhancing accuracy, and promoting equitable access. Without transparent pricing, it's challenging to definitively declare a winner in terms of overall value.

AgileMD's eCARTv5 is an FDA-cleared SaMD with established EHR integration, HIPAA compliance, and a SOC-II certification, indicating it is built to rigorous enterprise IT standards. It has been deployed at scale in hundreds of hospitals, demonstrating proven implementation and support for large healthcare systems. Google Med-PaLM 2, while HIPAA compliant and available through Google Cloud, is currently in a limited access phase for select customers, suggesting it is still maturing for widespread enterprise deployment and integration.

Google Med-PaLM 2 represents a significant innovation as a large language model specifically fine-tuned for healthcare, demonstrating expert-level performance on medical licensing exams and developing multimodal capabilities to interpret various medical data, including images. AgileMD's eCARTv5 is also innovative with its AI-powered clinical deterioration prediction and continuous risk assessment, but Med-PaLM 2's broader AI capabilities and multimodal approach push the boundaries of current healthcare AI applications.

AgileMD offers documentation, in-person, live online, videos, and webinars for training, along with email, phone, chat, FAQ, forum, help desk, knowledge base, tickets, and 24/7 live support. Google Med-PaLM 2, being an API, would likely rely on Google Cloud's extensive documentation and support, but specific healthcare-focused support and documentation for Med-PaLM 2 itself are not as explicitly detailed as AgileMD's offerings. However, as a Google product, it can be assumed that robust technical documentation and support channels are available.